Global Automated Breast Ultrasound Systems Market to surpass $ 1.9 Bn by 2025

January 10, 2020


According to the research report titled ‘Automated Breast Ultrasound Systems Market Size By Product (Automated Breast Ultrasound System {ABUS}, Automated Breast Volume Scanner {ABVS}), By End-use (Hospitals, Diagnostic Imaging Centers) Industry Analysis Report, Country Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Thailand, Brazil, Argentina, South Africa, UAE, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global automated breast ultrasound systems (ABUS) market is expected to cross USD 1.9 billion by the year 2025.
 

According to the report, rising prevalence of breast cancer coupled with advancements in technology associated with automated breast ultrasound system is a major factor driving the market growth. These advancements in ABUS helps to detect cancer in in females with dense breast tissues. For instance, ABUS based mammography systems increase the cancer detection rate by 55% in such women.
 

Increasing awareness pertaining to early detection of breast cancer in consort with favorable government initiatives, such as national breast screening programs, especially in Asia-Pacific and Europe are aiding the expansion of market. However, high costs of ABUS in the U.S. coupled with lack of skilled medical professionals in Asia-Pacific region will hinder the growth of the global automated breast ultrasound systems industry.
 

As per product type, ABVS (automated breast volume scanner) market segment held 43% share in the year 2018. Integration of ABVS with BI-RADS (breast imaging reporting and data system) and mammography system helps to accurately detect breast cancer in initial stages. the Growing occurrence of breast cancer is leading to rising adoption of ABVS across the globe.
 

In terms of end-use, the report cites that diagnostic imaging centers segment will grow with a CAGR of 16.6% during the period of 2019-2025. Rapid expansion of diagnostic centers in emerging economies is stimulating the industry outlook.
 

As per regional analysis the report states that Germany held a market valuation of USD 40.9 million in automated breast ultrasound systems industry in the year 2018. Availability of state-of-the-art healthcare facilities in tandem with rising prevalence of breast cancer is contributing towards the popularity of ABUS across the country.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/467783/
 

 On the other hand, China automated breast ultrasound systems market is predicted to grow with a CAGR of 17.6% between 2019-2025. The growth is attributed to growing geriatric population and increasing awareness regarding breast cancer.
 

The prominent companies operating in the automated breast cancer ultrasound industry are Volpara Solutions, Theraclion, SuperSonic Imagine, SonoCine Inc., Siemens AG, Shantou Institute of Ultrasonic Instruments Co. Ltd., Real Imaging, QView Medical Inc., Nova Medical Imaging Technology Co. Ltd, Metritrack Inc., Koninklijke Philips N.V., Hitachi Ltd., GE Healthcare, Delphinus Medical Technologies Inc., CapeRay Medical Ltd., and Canon Medical Systems.


Frequently Asked Questions (FAQ) :

According to the report, rising prevalence of breast cancer coupled with advancements in technology associated with automated breast ultrasound system is a major factor driving the market growth. These advancements in ABUS helps to detect cancer in in females with dense breast tissues. For instance, ABUS based mammography systems increases the cancer detection rate by 55% in such women. Increasing awareness pertaining to early detection of breast cancer in consort with favorable government initiatives, such as national breast screening programs, especially in Asia-Pacific and Europe are aiding the expansion of market.
ABVS (automated breast volume scanner) market segment held 43% share in the year 2018. Integration of ABVS with BI-RADS (breast imaging reporting and data system) and mammography system helps to accurately detect breast cancer in initial stages. The growing occurrence of breast cancer is leading to rising adoption of ABVS across the globe.
The report states that Germany held a market valuation of USD 40.9 million in automated breast ultrasound systems industry in the year 2018. Availability of state-of-the-art healthcare facilities in tandem with rising prevalence of breast cancer is contributing towards the popularity of ABUS across the country. On the other hand, China automated breast ultrasound systems market is predicted to grow with a CAGR of 17.6% between 2019-2025. The growth is attributed to growing geriatric population and increasing awareness regarding breast cancer.
The prominent companies operating in the automated breast cancer ultrasound industry are Volpara Solutions, Theraclion, SuperSonic Imagine, SonoCine Inc., Siemens AG, Shantou Institute of Ultrasonic Instruments Co. Ltd., Real Imaging, QView Medical Inc., Nova Medical Imaging Technology Co. Ltd, Metritrack Inc., Koninklijke Philips N.V., Hitachi Ltd., GE Healthcare, Delphinus Medical Technologies Inc., CapeRay Medical Ltd., and Canon Medical Systems.